Last reviewed · How we verify
STW 5-II
STW 5-II is a Herbal combination product Small molecule drug developed by Universitaire Ziekenhuizen KU Leuven. It is currently FDA-approved for Functional dyspepsia, Irritable bowel syndrome.
STW 5-II is a herbal combination product that modulates gastrointestinal motility and secretion to relieve functional gastrointestinal symptoms.
STW 5-II is a treatment being studied for Functional Dyspepsia, a type of Functional Gastrointestinal Disorder. It is being compared to a placebo in a clinical trial to assess its effects on duodenal mucosa and symptoms in patients with Functional Dyspepsia.
At a glance
| Generic name | STW 5-II |
|---|---|
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Drug class | Herbal combination product |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | FDA-approved |
Mechanism of action
STW 5-II contains a standardized extract of nine medicinal plants that work synergistically to improve gastric emptying, reduce visceral pain, and normalize intestinal secretion. The formulation addresses multiple pathophysiological mechanisms underlying functional dyspepsia and irritable bowel syndrome through its spasmolytic, prokinetic, and anti-inflammatory properties.
Approved indications
- Functional dyspepsia
- Irritable bowel syndrome
Common side effects
- Gastrointestinal disturbances
- Allergic reactions
Key clinical trials
- The Effects of STW 5-II on Duodenal Mucosa and Symptoms in Functional Dyspepsia (PHASE4)
- A Pharmacy-based Observational Study to Learn More About Iberogast Advance in the Real-world Setting
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- STW 5-II CI brief — competitive landscape report
- STW 5-II updates RSS · CI watch RSS
- Universitaire Ziekenhuizen KU Leuven portfolio CI
Frequently asked questions about STW 5-II
What is STW 5-II?
How does STW 5-II work?
What is STW 5-II used for?
Who makes STW 5-II?
What drug class is STW 5-II in?
What development phase is STW 5-II in?
What are the side effects of STW 5-II?
Related
- Drug class: All Herbal combination product drugs
- Manufacturer: Universitaire Ziekenhuizen KU Leuven — full pipeline
- Therapeutic area: All drugs in Gastroenterology
- Indication: Drugs for Functional dyspepsia
- Indication: Drugs for Irritable bowel syndrome
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing